Literature DB >> 12954741

Chronic renal failure after transplantation of a nonrenal organ.

Akinlolu O Ojo1, Philip J Held, Friedrich K Port, Robert A Wolfe, Alan B Leichtman, Eric W Young, Julie Arndorfer, Laura Christensen, Robert M Merion.   

Abstract

BACKGROUND: Transplantation of nonrenal organs is often complicated by chronic renal disease with multifactorial causes. We conducted a population-based cohort analysis to evaluate the incidence of chronic renal failure, risk factors for it, and the associated hazard of death in recipients of nonrenal transplants.
METHODS: Pretransplantation and post-transplantation clinical variables and data from a registry of patients with end-stage renal disease (ESRD) were linked in order to estimate the cumulative incidence of chronic renal failure (defined as a glomerular filtration rate of 29 ml per minute per 1.73 m2 of body-surface area or less or the development of ESRD) and the associated risk of death among 69,321 persons who received nonrenal transplants in the United States between 1990 and 2000.
RESULTS: During a median follow-up of 36 months, chronic renal failure developed in 11,426 patients (16.5 percent). Of these patients, 3297 (28.9 percent) required maintenance dialysis or renal transplantation. The five-year risk of chronic renal failure varied according to the type of organ transplanted - from 6.9 percent among recipients of heart-lung transplants to 21.3 percent among recipients of intestine transplants. Multivariate analysis indicated that an increased risk of chronic renal failure was associated with increasing age (relative risk per 10-year increment, 1.36; P<0.001), female sex (relative risk among male patients as compared with female patients, 0.74; P<0.001), pretransplantation hepatitis C infection (relative risk, 1.15; P<0.001), hypertension (relative risk, 1.18; P<0.001), diabetes mellitus (relative risk, 1.42; P<0.001), and postoperative acute renal failure (relative risk, 2.13; P<0.001). The occurrence of chronic renal failure significantly increased the risk of death (relative risk, 4.55; P<0.001). Treatment of ESRD with kidney transplantation was associated with a five-year risk of death that was significantly lower than that associated with dialysis (relative risk, 0.56; P=0.02).
CONCLUSIONS: The five-year risk of chronic renal failure after transplantation of a nonrenal organ ranges from 7 to 21 percent, depending on the type of organ transplanted. The occurrence of chronic renal failure among patients with a nonrenal transplant is associated with an increase by a factor of more than four in the risk of death. Copyright 2003 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2003        PMID: 12954741     DOI: 10.1056/NEJMoa021744

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  355 in total

1.  The influence of induction therapy for kidney transplantation after a non-renal transplant.

Authors:  James R Cassuto; Matthew H Levine; Peter P Reese; Roy D Bloom; Simin Goral; Ali Naji; Peter L Abt
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Lung retransplantation.

Authors:  Steven M Kawut
Journal:  Clin Chest Med       Date:  2011-06       Impact factor: 2.878

3.  Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.

Authors:  Zhen-Yong Shao; Lu-Nan Yan; Wen-Tao Wang; Bo Li; Tian-Fu Wen; Jia-Yin Yang; Ming-Qing Xu; Ji-Chun Zhao; Yong-Gang Wei
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

4.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Authors:  Kristina I Rother; David M Harlan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

5.  Past, present, and future prospects for inducing donor-specific transplantation tolerance for composite tissue allotransplantation.

Authors:  Larry D Bozulic; Warren C Breidenbach; Suzanne T Ildstad
Journal:  Semin Plast Surg       Date:  2007-11       Impact factor: 2.314

6.  Comparing 10-yr renal outcomes in deceased donor and living donor liver transplants.

Authors:  Shaifali Sandal; Anthony Almudevar; Sandesh Parajuli; Anirban Bose
Journal:  Clin Transplant       Date:  2015-11-05       Impact factor: 2.863

7.  Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies.

Authors:  Yaojen Chang; Lorenzo Gallon; Kirti Shetty; Yuchia Chang; Colleen Jay; Josh Levitsky; Bing Ho; Talia Baker; Daniela Ladner; John Friedewald; Michael Abecassis; Gordon Hazen; Anton I Skaro
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

Review 8.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

9.  Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy.

Authors:  Yaojen Chang; Lorenzo Gallon; Colleen Jay; Kirti Shetty; Bing Ho; Josh Levitsky; Talia Baker; Daniela Ladner; John Friedewald; Michael Abecassis; Gordon Hazen; Anton I Skaro
Journal:  Liver Transpl       Date:  2014-09       Impact factor: 5.799

10.  Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation.

Authors:  Lisa B VanWagner; Samantha Montag; Lihui Zhao; Norrina B Allen; Donald M Lloyd-Jones; Arighno Das; Anton I Skaro; Samuel Hohmann; John J Friedewald; Josh Levitsky
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.